Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Mephedrone to be banned

Mephedrone was banned this week (16 April 2010) following recommendations from the Advisory Council on the Misuse of Drugs.

Currently sold as a plant food alongside others in the cathinone group, mephedrone will be classified as a Class B drug.

Speaking in the House of Commons this week (7 April 2010) Home Office minister Alan Campbell said: “These controls also look to deal with future trends to stop unscrupulous illicit manufacturers working for organised criminals who seek to tweak substances to circumvent our laws.”

Following media reports that anyone who has used mephedrone should seek medical attention, the Department of Health advises that only those with acute toxic effects should be referred to an accident and emergency department. Less severe or less acute physical or psychological problems should be assessed and managed symptomatically as for any other users of psychoactive drugs, the DoH adds.

 

 

Citation: The Pharmaceutical Journal URI: 11006477

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.